Clozapine conflict [6]

American Journal of Psychiatry

Volumn 153, Issue 11, 1996, Pages 1505-1508

  Carpenter W T , Jr ^a   Conley, R R ^a   Buchanan, R W ^a   Breier, A ^a   Tamminga, C A ^a   Kane, J M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

DRUG EFFICACY; DRUG HALF LIFE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LETTER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TARDIVE DYSKINESIA; CLINICAL TRIAL; COGNITIVE DEFECT; METHODOLOGY; NOTE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; STANDARD; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; CLOZAPINE; COGNITION DISORDERS; HUMANS; RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0030294335     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)